Related Experiment Video
Updated: Apr 23, 2026

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
Circulating biomarker panels for targeted therapy in brain tumors
Cristiana Tanase1, Radu Albulescu, Elena Codrici
1Victor Babes National Institute of Pathology, Biochemistry-Proteomics Department, no 99-101 Splaiul Independentei, 050096 Sector 5 Bucharest, Romania.
Developing cancer risk-identifier biomarkers is crucial for early detection and targeted therapy in oncology. This research explores circulating biomarker panels for effective brain tumor monitoring and personalized medicine.
Area of Science:
- Oncology
- Biomarker Discovery
- Proteomics
Background:
- Early cancer detection and targeted therapy are key goals in oncology.
- High-throughput profiling is essential for brain tumor research.
- Circulating biomarker panels offer a promising approach for monitoring disease progression and therapy.
Purpose of the Study:
- To review current data on biomarker candidates for brain tumors.
- To address challenges in brain tumor biomarker development.
- To explore future perspectives for effective predictive biomarker panels.
Main Methods:
- Literature review of current biomarker candidates.
- Analysis of challenges in biomarker field.
- Exploration of future perspectives for predictive biomarker panels.
Main Results:
- Identified key challenges in brain tumor biomarker development.
- Highlighted the potential of circulating biomarker panels.
- Discussed tailoring treatment through protein interactions, signaling networks, microRNA, and cancer stem cell signaling.
Conclusions:
- Personalized medicine for brain tumors relies on tailored treatments based on biomarker panels.
- Further development of predictive biomarker panels is essential for effective brain tumor management.
More Related Videos
08:12Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies